2025 fourth_quarter Filing
Q4Income
$80K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (5)
CRISTINA ANTELO
DEBRA DIXON
MARK WILLIAMS
MICHAEL TAGGART